Striated muscle activator of Rho signalling (STARS) is a PGC-1α/oestrogen-related receptor-α target gene and is upregulated in human skeletal muscle after endurance exercise

Journal of Physiology

Volumn 589, Issue 8, 2011, Pages 2027-2039

  Wallace, Marita A ^a   Hock, M Benjamin ^b   Hazen, Bethany C ^b   Kralli, Anastasia ^b   Snow, Rod J ^a   Russell, Aaron P ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; CARNITINE PALMITOYLTRANSFERASE 1BETA; CARNITINE PALMITOYLTRANSFERASE I; CYCLOOXYGENASE 4; ESTROGEN RELATED RECEPTOR ALPHA; MESSENGER RNA; MRTF A PROTEIN; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROSTAGLANDIN SYNTHASE; SERUM RESPONSE FACTOR; STRIATED MUSCLE ACTIVATOR OF RHO SIGNALLING PROTEIN; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDURANCE TRAINING; GENE OVEREXPRESSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MYOTUBE; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION;

ADULT; ANALYSIS OF VARIANCE; ANIMALS; BICYCLING; BINDING SITES; BIOPSY; CARNITINE O-PALMITOYLTRANSFERASE; CELL LINE; DNA-BINDING PROTEINS; ENERGY METABOLISM; HEAT-SHOCK PROTEINS; HUMANS; MALE; MICE; MICROFILAMENT PROTEINS; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; ONCOGENE PROTEINS, FUSION; PHYSICAL ENDURANCE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ESTROGEN; RNA INTERFERENCE; RNA, MESSENGER; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION; YOUNG ADULT;

EID: 79954557003     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.205468     Document Type: Article

References (53)

1. Arai A, Spencer JA & Olson EN (2002). STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem 277, 24453-24459.
2. Bassel-Duby R & Olson EN (2006). Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75, 19-37.
3. Bergstrom J (1962). Muscle electrolytes in man. Scand J Clin Invest Suppl 14, 1-110.
4. Booth FW, Chakravarthy MV & Spangenburg EE (2002). Exercise and gene expression: physiological regulation of the human genome through physical activity. J Physiol 543, 399-411.
5. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S et al (2005). Mitofusins 1/2 and ERRα expression are increased in human skeletal muscle after physical exercise. J Physiol 567, 349-358.
6. Charvet C, Houbron C, Parlakian A, Giordani J, Lahoute C, Bertrand A et al (2006). New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways. Mol Cell Biol 26, 6664-6674.
7. Evans WJ, Phinney SD & Young VR (1982). Suction applied to a muscle biopsy maximizes sample size. Med Sci Sports Exerc 14, 101-102.
8. Favier FB, Benoit H & Freyssenet D (2008). Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch 456, 587-600.
9. Franco CA, Mericskay M, Parlakian A, Gary-Bobo G, Gao-Li J, Paulin D, Gustafsson E & Li Z (2008). Serum response factor is required for sprouting angiogenesis and vascular integrity. Dev Cell 15, 448-461.
10. Giger JM, Bodell PW, Zeng M, Baldwin KM & Haddad F (2009). Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin. J Appl Physiol 107, 1204-1212.
11. Hawke TJ (2005). Muscle stem cells and exercise training. Exerc Sport Sci Rev 33, 63-68.
12. Hawley JA, Hargreaves M & Zierath JR (2006). Signalling mechanisms in skeletal muscle: role in substrate selection and muscle adaptation. Essays Biochem 42, 1-12.
13. Hock MB & Kralli A (2009). Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 71, 177-203.
14. Hood DA (2009). Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle. Appl Physiol Nutr Metab 34, 465-472.
15. Knutti D & Kralli A (2001). PGC-1, a versatile coactivator. Trends Endocrinol Metab 12, 360-365.
16. Koekemoer AL. (2009). Myocyte stress 1 plays an important role in cellular hypertrophy and protection against apoptosis. FEBS Lett 583, 2964-2967.
17. Koulmann N & Bigard AX (2006). Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise. Pflugers Arch 452, 125-139.
18. Koutroumpi M, Pitsavos C & Stefanadis C (2008). The role of exercise in cardiovascular rehabilitation: a review. Acta Cardiol 63, 73-79.
19. Kuwahara K, Barrientos T, Pipes GC, Li S & Olson EN (2005). Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol 25, 3173-3181.
20. Kuwahara K, Teg Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R & Olson EN (2007). Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Invest 117, 1324-1334.
21. Lahoute C, Sotiropoulos A, Favier M, Guillet-Deniau I, Charvet C, Ferry A et al (2008). Premature aging in skeletal muscle lacking serum response factor. PLoS One 3, e3910.
22. Lamon S, Wallace MA, Leger B & Russell AP (2009). Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy. J Physiol 587, 1795-1803.
23. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A et al (2006a). Akt signalling through GSK-3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 576, 923-933.
24. Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C et al (2006b). Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20, 583-585.
25. Lindecke A, Korte M, Zagrebelsky M, Horejschi V, Elvers M, Widera D et al (2006). Long-term depression activates transcription of immediate early transcription factor genes: involvement of serum response factor/Elk-1. Eur J Neurosci 24, 555-563.
26. Ling C, Poulsen P, Carlsson E, Ridderstrale M, Almgren P, Wojtaszewski J et al (2004). Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins. J Clin Invest 114, 1518-1526.
27. McGee SL, Sparling D, Olson AL & Hargreaves M (2006). Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle. FASEB J 20, 348-349.
28. Mahadeva H, Brooks G, Lodwick D, Chong NW & Samani NJ (2002). ms1, a novel stress-responsive, muscle-specific gene that is up-regulated in the early stages of pressure overload-induced left ventricular hypertrophy. FEBS Lett 521, 100-104.
29. Miano JM, Long X & Fujiwara K (2007). Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292, C70-C81.
30. Miralles F, Posern G, Zaromytidou AI & Treisman R (2003). Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329-342.
31. Moore ML, Park EA & McMillin JB (2003). Upstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Ibeta expression by PGC-1. J Biol Chem 278, 17263-17268.
32. Moore ML, Wang GL, Belaguli NS, Schwartz RJ & McMillin JB (2001). GATA-4 and serum response factor regulate transcription of the muscle-specific carnitine palmitoyltransferase I β in rat heart. J Biol Chem 276, 1026-1033.
33. Oishi Y, Ogata T, Yamamoto KI, Terada M, Ohira T, Ohira Y et al (2008). Cellular adaptations in soleus muscle during recovery after hindlimb unloading. Acta Physiol (Oxf) 192, 381-395.
34. Ounzain S, Dacwag CS, Samani NJ, Imbalzano AN & Chong NW (2008). Comparative in silico analysis identifies bona fide MyoD binding sites within the myocyte stress 1 gene promoter. BMC Mol Biol 9, 50.
35. Park JY, Farrance IK, Fenty NM, Hagberg JM, Roth SM, Mosser DM et al (2007). NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Am J Physiol Heart Circ Physiol 293, H2320-H2327.
36. Puntschart A, Wey E, Jostarndt K, Vogt M, Wittwer M, Widmer HR et al (1998). Expression of fos and jun genes in human skeletal muscle after exercise. Am J Physiol Cell Physiol 274, C129-C137.
37. 2+ calmodulin-dependent protein kinase II expression and signalling in skeletal muscle of humans. J Physiol 583, 785-795.
38. Russell AP (2010). The molecular regulation of skeletal muscle mass. Clin Exp Pharmacol Physiol 37, 378-384.
39. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C et al (2003a). Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 52, 2874-2881.
40. Russell AP, Hesselink MK, Lo SK & Schrauwen P (2005). Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB J 19, 986-988.
41. Russell AP, Somm E, Debigare R, Hartley O, Richard D, Gastaldi G et al (2004). COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibers. J Cardiopulm Rehabil 24, 332-339.
42. Russell AP, Wadley G, Hesselink MK, Schaart G, Lo S, Leger B et al (2003b). UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjects. Pflugers Arch 445, 563-569.
43. Sakuma K, Akiho M, Nakashima H, Akima H & Yasuhara M (2008). Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles. Biochim Biophys Acta 1782, 453-461.
44. Sakuma K, Watanabe K, Hotta N, Koike T, Ishida K, Katayama K & Akima H (2009). The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans. Acta Physiol (Oxf) 197, 151-159.
45. Schiaffino S, Sandri M & Murgia M (2007). Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 22, 269-278.
46. Schrauwen P & Hesselink MK (2004). Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53, 1412-1417.
47. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M et al (2004). The estrogen-related receptor alpha (ERRα) functions in PPARgamma coactivator 1alpha (PGC-1α)-induced mitochondrial biogenesis. Proc Natl Acad Sci U S A 101, 6472-6477.
48. Sladek R, Beatty B, Squire J, Copeland NG, Gilbert DJ, Jenkins NA & Giguere V (1997). Chromosomal mapping of the human and murine orphan receptors ERRα (ESRRA) and ERRβ (ESRRB) and identification of a novel human ERRα-related pseudogene. Genomics 45, 320-326.
49. Sotiropoulos A, Gineitis D, Copeland J & Treisman R (1999). Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159-169.
50. Troidl K, Ruding I, Cai WJ, Mucke Y, Grossekettler L, Piotrowska I et al (2009). Actin-binding rho activating protein (Abra) is essential for fluid shear stress-induced arteriogenesis. Arterioscler Thromb Vasc Biol 29, 2093-2101.
51. Ventura-Clapier R, Mettauer B & Bigard X (2007). Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 73, 10-18.
52. Villena JA, Hock MB, Chang WY, Barcas JE, Giguere V & Kralli A (2007). Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. Proc Natl Acad Sci U S A 104, 1418-1423.
53. Zhang K, Lu J, Mori T, Smith-Powell L, Synold TW, Chen S & Wen W (2011). Baicalin increases VEGF expression and angiogenesis by activating the ERRα/PGC-1α pathway. Cardiovasc Res 89, 426-435.